Charming Medical Limited (MCTA)
NASDAQ: MCTA · Real-Time Price · USD
29.36
0.00 (-0.02%)
Nov 11, 2025, 4:00 PM EST - Market closed

Charming Medical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023
Period Ending
Mar '25 Mar '24 Mar '23
Net Income
1.20.78-0.31
Depreciation & Amortization
0.260.390.21
Loss (Gain) From Sale of Investments
-0--
Other Operating Activities
0.130.070.03
Change in Accounts Receivable
-0.04-0.16-0.15
Change in Inventory
00.04-0.06
Change in Accounts Payable
-0.20.210.18
Change in Unearned Revenue
-1.06-1.112.73
Change in Income Taxes
0.10.12-
Change in Other Net Operating Assets
0.04-0.04-0.11
Operating Cash Flow
0.430.32.43
Operating Cash Flow Growth
44.16%-87.86%-
Capital Expenditures
-0.29-0.21-0.61
Investment in Securities
-1.94--
Investing Cash Flow
-2.23-0.21-0.61
Long-Term Debt Issued
0.210.04-
Short-Term Debt Repaid
-0.13-0.15-0.18
Long-Term Debt Repaid
-0.03-0.01-
Total Debt Repaid
-0.16-0.15-0.18
Net Debt Issued (Repaid)
0.05-0.12-0.18
Other Financing Activities
0.470.22-1.25
Financing Cash Flow
0.520.1-1.43
Foreign Exchange Rate Adjustments
-0-0.010.01
Net Cash Flow
-1.290.170.4
Free Cash Flow
0.140.081.83
Free Cash Flow Growth
63.10%-95.36%-
Free Cash Flow Margin
2.22%1.41%51.76%
Free Cash Flow Per Share
0.010.010.12
Cash Interest Paid
0.020.030.02
Levered Free Cash Flow
10.75-
Unlevered Free Cash Flow
1.010.76-
Change in Working Capital
-1.16-0.942.5
Source: S&P Capital IQ. Standard template. Financial Sources.